9CLZ image
Deposition Date 2024-07-12
Release Date 2025-07-16
Last Version Date 2025-09-17
Entry Detail
PDB ID:
9CLZ
Title:
Novel designed icosahedral nanoparticle I3-A6
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.50 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:I3-A6
Chain IDs:A (auth: 0), B (auth: 1), C (auth: 2), D (auth: 3), E (auth: 4), F (auth: 5), G (auth: 6), H (auth: 7), I (auth: 8), J (auth: 9), K (auth: A), L (auth: B), M (auth: C), N (auth: D), O (auth: E), P (auth: F), Q (auth: G), R (auth: H), S (auth: I), T (auth: J), U (auth: K), V (auth: L), W (auth: M), X (auth: N), Y (auth: O), Z (auth: P), AA (auth: Q), BA (auth: R), CA (auth: S), DA (auth: T), EA (auth: U), FA (auth: V), GA (auth: W), HA (auth: X), IA (auth: Y), JA (auth: Z), KA (auth: c), LA (auth: d), MA (auth: e), NA (auth: f), OA (auth: g), PA (auth: h), QA (auth: i), RA (auth: j), SA (auth: k), TA (auth: l), UA (auth: m), VA (auth: n), WA (auth: o), XA (auth: p), YA (auth: q), ZA (auth: r), AB (auth: s), BB (auth: t), CB (auth: u), DB (auth: v), EB (auth: w), FB (auth: x), GB (auth: y), HB (auth: z)
Chain Length:192
Number of Molecules:60
Biological Source:Escherichia coli BL21
Ligand Molecules
Primary Citation
From sequence to scaffold: computational design of protein nanoparticle vaccines from AlphaFold2-predicted building blocks.
Biorxiv ? ? ? (2025)
PMID: 40894567 DOI: 10.1101/2025.08.20.671178

Abstact

Self-assembling protein nanoparticles are being increasingly utilized in the design of next-generation vaccines due to their ability to induce antibody responses of superior magnitude, breadth, and durability. Computational protein design offers a route to novel nanoparticle scaffolds with structural and biochemical features tailored to specific vaccine applications. Although strategies for designing new self-assembling proteins have been established, the recent development of powerful machine learning-based tools for protein structure prediction and design provides an opportunity to overcome several of their limitations. Here, we leveraged these tools to develop a generalizable method for designing novel self-assembling proteins starting from AlphaFold2 predictions of oligomeric protein building blocks. We used the method to generate six new 60-subunit protein nanoparticles with icosahedral symmetry, and single-particle cryo-electron microscopy reconstructions of three of them revealed that they were designed with atomic-level accuracy. To transform one of these nanoparticles into a functional immunogen, we reoriented its termini through circular permutation, added a genetically encoded oligomannose-type glycan, and displayed a stabilized trimeric variant of the influenza hemagglutinin receptor binding domain through a rigid de novo linker. The resultant immunogen elicited potent receptor-blocking and neutralizing antibody responses in mice. Our results demonstrate the practical utility of machine learning-based protein modeling tools in the design of nanoparticle vaccines. More broadly, by eliminating the requirement for experimentally determined structures of protein building blocks, our method dramatically expands the number of starting points available for designing new self-assembling proteins.

Legend

Protein

Chemical

Disease

Primary Citation of related structures